Dr. Brian Scott Lerner, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Attn: Cyndi Miles Family Medicine Residency Coordinator, Ft Belvoir, VA 22060 Phone: 571-231-1803 |
William Edwards Bynum Iv, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9501 Farrell Rd, Ft Belvoir, VA 22060 Phone: 703-805-0146 |
Dr. Abigail Lea Axel, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Ft Belvoir, VA 22060 Phone: 503-333-6500 |
Dr. Elizabeth Anne Greene, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Ft Belvoir, VA 22060 Phone: 571-231-4624 Fax: 240-857-3011 |
Dr. Jason Alexander Macdonnell, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5997 Halleck Blvd, Ft Belvoir, VA 22060 Phone: 703-781-0798 |
Brian Lee, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Family Medicine, Ft Belvoir, VA 22060 Phone: 571-231-1994 |
Syed Ali, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Ft Belvoir Community Hospital Family Medicine Clinic, Ft Belvoir, VA 22060 Phone: 571-231-1994 |
Dr. Adam Ibrahim Rifaat, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Fort Belvoir Community Hospital, 9300 Dewitt Loop, Ft Belvoir, VA 22060 Phone: 908-581-6247 |
Dr. Nathaniel Stephen Nye, MD Family Medicine - Sports Medicine Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Ft Belvoir, VA 22060 Phone: 571-231-2894 |
Wyatt Maloy, M.D. Family Medicine - Sports Medicine Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Ft Belvoir, VA 22060 Phone: 301-580-0055 |
News Archive
A new study from the University of East Anglia describes a novel approach to detecting bacteria and viruses that may possibly be causing cancer. Many such associations have already been found, such as HPV (human papilloma virus) infection in cervical cancer, and Helicobacter pylori (H. pylori) in stomach cancer.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
The traditional approach to psychiatric diagnosis is based on grouping patients on the basis of symptom clusters. This approach to diagnosis has a number of problems, as symptoms are not necessarily specific to a single diagnosis.
Evotec AG today announced the signing of a definitive agreement to acquire all shares in Kinaxo Biotechnologies GmbH, a Munich-based drug discovery alliance company supporting the development of targeted drugs.
› Verified 9 days ago